SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?


To: Rich Powers who wrote (502)6/29/1998 12:36:00 PM
From: Joe Dancy  Read Replies (1) | Respond to of 696
 
Did not learn any more about the BIOI internet presentation, other than it has not moved the stock :).

ETHCY is a real speculation - you will either do real well or lose it at this point - I have a call and inquiry into the company. I've bought more in the last month, and asked to be considered to be appointed to the Board of Directors to replace one of the three that left.

I'd put my money in BIOI or UCOR before ETHCY - at least until it becomes more clear where ETHCY will go with regard to financing or new stock issuance. BIOI and UCOR are real stable companies, low debt, good mangement, undervalued, in the health sector so are somewhat immune from the Asian flu.

Of course, at the ETHCY price the bad news is all out IMO. Then again, maybe not.

Joe



To: Rich Powers who wrote (502)7/3/1998 12:49:00 PM
From: Joe Dancy  Read Replies (2) | Respond to of 696
 
On a projected growth to pe basis BIOI looks the best among the companies I follow and have been acquiring:

members.aol.com

Lets hope the quarters numbers don't disappoint - I have a feeling that they will not.

Also, I forgot that the conference can be accessed for 90 days - I'll report what they said if I can find time to watch it.

Also, I've done a bunch of research into ETHCY recently, very speculative, but you can see what I dug up and posted over there - plus they just announced a new financing deal with ELN.

Joe



To: Rich Powers who wrote (502)7/7/1998 2:08:00 PM
From: Joe Dancy  Read Replies (2) | Respond to of 696
 
Listened to internet presentation today. Was really neat and well done by both the company and the Wall Street Forum. Did not say anything we did not already know, but here is my two paragraph summary FWIW:
***************************
BIOSOURCE INTERNATIONAL (BIOI)
The company made a presentation to analysts at a Wall Street Forum conference carried over the Internet on June 22nd. The CEO noted that the company provides research and diagnostic tools to the biotechnology sector - and that AIDS, cancer, and related research would drive growth of this sector of the biotech market upward at a 20% annual rate for the foreseeable future.

BIOI developed 246 products internally last year and will exceed that number this year, and now sells over 17,000 research related products. It has an international distribution network for its products, and faces minimal regulatory hurdles in getting the research products approved for sale. The company expects revenues to continue to grow strongly this year, has a "very aggressive" share buyback program in place and plans to continue to repurchase shares, and has a strong balance sheet with lots of cash available for the repurchase program.

Joe